Publication | Open Access
Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib
40
Citations
19
References
2020
Year
Everolimus was associated with modest PFS and ORR in HR+ HER2-MBCs postprogression on palbociclib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1